<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35764621</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>28</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records.</ArticleTitle><Pagination><StartPage>3528</StartPage><MedlinePgn>3528</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3528</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-022-30836-0</ELocationID><Abstract><AbstractText>The frequency of, and risk factors for, long COVID are unclear among community-based individuals with a history of COVID-19. To elucidate the burden and possible causes of long COVID in the community, we coordinated analyses of survey data from 6907 individuals with self-reported COVID-19 from 10 UK longitudinal study (LS) samples and 1.1 million individuals with COVID-19 diagnostic codes in electronic healthcare records (EHR) collected by spring 2021. Proportions of presumed COVID-19 cases in LS reporting any symptoms for 12+ weeks ranged from 7.8% and 17% (with 1.2 to 4.8% reporting debilitating symptoms). Increasing age, female sex, white ethnicity, poor pre-pandemic general and mental health, overweight/obesity, and asthma were associated with prolonged symptoms in both LS and EHR data, but findings for other factors, such as cardio-metabolic parameters, were inconclusive.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Thompson</LastName><ForeName>Ellen J</ForeName><Initials>EJ</Initials><Identifier Source="ORCID">0000-0003-2118-821X</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, School of Life Course Sciences, King's College London, London, UK. ellen.thompson@kcl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Williams</LastName><ForeName>Dylan M</ForeName><Initials>DM</Initials><Identifier Source="ORCID">0000-0002-3825-2487</Identifier><AffiliationInfo><Affiliation>MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK. dylan.williams@ucl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. dylan.williams@ucl.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Walker</LastName><ForeName>Alex J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0003-4932-6135</Identifier><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxfort, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitchell</LastName><ForeName>Ruth E</ForeName><Initials>RE</Initials><Identifier Source="ORCID">0000-0002-3506-160X</Identifier><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niedzwiedz</LastName><ForeName>Claire L</ForeName><Initials>CL</Initials><Identifier Source="ORCID">0000-0001-6133-4168</Identifier><AffiliationInfo><Affiliation>Institute of Health &amp; Wellbeing, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Tiffany C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huggins</LastName><ForeName>Charlotte F</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwong</LastName><ForeName>Alex S F</ForeName><Initials>ASF</Initials><Identifier Source="ORCID">0000-0003-1953-2771</Identifier><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Psychiatry, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silverwood</LastName><ForeName>Richard J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0002-2744-1194</Identifier><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Gessa</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6154-1845</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowyer</LastName><ForeName>Ruth C E</ForeName><Initials>RCE</Initials><Identifier Source="ORCID">0000-0002-6941-8160</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, School of Life Course Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Northstone</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Bo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-3193-2452</Identifier><AffiliationInfo><Affiliation>MRC/CSO Social &amp; Public Health Sciences Unit, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dodgeon</LastName><ForeName>Brian</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doores</LastName><ForeName>Katie J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0002-5507-1725</Identifier><AffiliationInfo><Affiliation>School of Immunology &amp; Microbial Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duncan</LastName><ForeName>Emma L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0002-8143-4403</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, School of Life Course Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Frances M K</ForeName><Initials>FMK</Initials><Identifier Source="ORCID">0000-0002-2998-2744</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, School of Life Course Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>OpenSAFELY Collaborative</CollectiveName></Author><Author ValidYN="Y"><LastName>Steptoe</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7808-4943</Identifier><AffiliationInfo><Affiliation>Department of Epidemiology and Public Health, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porteous</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0003-1249-6106</Identifier><AffiliationInfo><Affiliation>Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McEachan</LastName><ForeName>Rosemary R C</ForeName><Initials>RRC</Initials><AffiliationInfo><Affiliation>Bradford Institute for Health Research, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, BD9 6RJ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>Laurie</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8848-9493</Identifier><AffiliationInfo><Affiliation>Electronic Health Records Research Group, Faculty of Epidemiology and Population Health, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goldacre</LastName><ForeName>Ben</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxfort, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patalay</LastName><ForeName>Praveetha</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ploubidis</LastName><ForeName>George B</ForeName><Initials>GB</Initials><AffiliationInfo><Affiliation>Centre for Longitudinal Studies, UCL Social Research Institute, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katikireddi</LastName><ForeName>Srinivasa Vittal</ForeName><Initials>SV</Initials><Identifier Source="ORCID">0000-0001-6593-9092</Identifier><AffiliationInfo><Affiliation>MRC/CSO Social &amp; Public Health Sciences Unit, University of Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tilling</LastName><ForeName>Kate</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1010-8926</Identifier><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rentsch</LastName><ForeName>Christopher T</ForeName><Initials>CT</Initials><Identifier Source="ORCID">0000-0002-1408-7907</Identifier><AffiliationInfo><Affiliation>Electronic Health Records Research Group, Faculty of Epidemiology and Population Health, London School of Hygiene &amp; Tropical Medicine, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VA Connecticut Healthcare System, West Haven, CT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Timpson</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><Identifier Source="ORCID">0000-0002-7141-9189</Identifier><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit at the University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaturvedi</LastName><ForeName>Nishi</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6211-2775</Identifier><AffiliationInfo><Affiliation>MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Steves</LastName><ForeName>Claire J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-4910-0489</Identifier><AffiliationInfo><Affiliation>Department of Twin Research and Genetic Epidemiology, School of Life Course Sciences, King's College London, London, UK. claire.j.steves@kcl.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ageing and Health, Guys and St Thomas's NHS Foundation Trust, London, UK. claire.j.steves@kcl.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COV-LT-0009</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>217065/Z/19/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SCAF/15/02</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>104036/Z/14/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20051</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_15018</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WT101597MA</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>202802/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P023444/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_19009</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CZD/16/6</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20030</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00011/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>C18281/A29019</GrantID><Acronym>CRUK_</Acronym><Agency>Cancer Research UK</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20059</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>221574/Z/20/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>CS/16/4/32482</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00019/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R024774/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00019/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/V015737/</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>NIHR200166</GrantID><Acronym>DH_</Acronym><Agency>Department of Health</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00022/2</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>G9815508</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>216767/Z/19/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00011/3</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N024397/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>204813/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SPHSU17</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WT212904/Z/18/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_PC_20058</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057286" MajorTopicYN="Y">Electronic Health Records</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>No competing interests were declared by E.J.T., D.M.W., A.J.W., R.E.M., C.L.N., T.C.Y., C.F.H., A.S.F.K., R.J.S., G.D., R.C.E.B., K.N. B.H., M.J.G., B.D., K.J.D., E.L.D., F.M.K.W., A.S., L.T., B.G., P.P., G.B.P., K.T., C.T.R., N.J.T., N.C., C.J.S. B.G. has received research funding from the Laura and John Arnold Foundation, the NHS National Institute for Health Research (NIHR), the NIHR School of Primary Care Research, the NIHR Oxford Biomedical Research Centre, the Mohn-Westlake Foundation, NIHR Applied Research Collaboration Oxford and Thames Valley, the Wellcome Trust, the Good Thinking Foundation, Health Data Research UK (HDRUK), the Health Foundation, and the World Health Organisation; he also receives personal income from speaking and writing for lay audiences on the misuse of science. S.V.K. is a member of the Scientific Advisory Group on Emergencies subgroup on ethnicity and COVID-19 and is co-chair of the Scottish Government&#x2019;s Ethnicity Reference Group on COVID-19. N.C. serves on a data safety monitoring board for trials sponsored by AstraZeneca. C.J.S. is an academic lead on KCL Zoe Global Ltd. COVID symptoms study. The remaining authors declare no competing interests.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Walker</LastName><ForeName>Alex J</ForeName><Initials>AJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>MacKenna</LastName><ForeName>Brian</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Inglesby</LastName><ForeName>Peter</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Rentsch</LastName><ForeName>Christopher T</ForeName><Initials>CT</Initials></Investigator><Investigator ValidYN="Y"><LastName>Curtis</LastName><ForeName>Helen J</ForeName><Initials>HJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morton</LastName><ForeName>Caroline E</ForeName><Initials>CE</Initials></Investigator><Investigator ValidYN="Y"><LastName>Morley</LastName><ForeName>Jessica</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mehrkar</LastName><ForeName>Amir</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bacon</LastName><ForeName>Seb</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hickman</LastName><ForeName>George</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bates</LastName><ForeName>Chris</ForeName><Initials>C</Initials></Investigator><Investigator ValidYN="Y"><LastName>Croker</LastName><ForeName>Richard</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>David</ForeName><Initials>D</Initials></Investigator><Investigator ValidYN="Y"><LastName>Ward</LastName><ForeName>Tom</ForeName><Initials>T</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cockburn</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Davy</LastName><ForeName>Simon</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bhaskaran</LastName><ForeName>Krishnan</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Schultze</LastName><ForeName>Anna</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Williamson</LastName><ForeName>Elizabeth J</ForeName><Initials>EJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hulme</LastName><ForeName>William J</ForeName><Initials>WJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>McDonald</LastName><ForeName>Helen I</ForeName><Initials>HI</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tomlinson</LastName><ForeName>Laurie</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mathur</LastName><ForeName>Rohini</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Eggo</LastName><ForeName>Rosalind M</ForeName><Initials>RM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wing</LastName><ForeName>Kevin</ForeName><Initials>K</Initials></Investigator><Investigator ValidYN="Y"><LastName>Wong</LastName><ForeName>Angel Y S</ForeName><Initials>AYS</Initials></Investigator><Investigator ValidYN="Y"><LastName>Forbes</LastName><ForeName>Harriet</ForeName><Initials>H</Initials></Investigator><Investigator ValidYN="Y"><LastName>Tazare</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Parry</LastName><ForeName>John</ForeName><Initials>J</Initials></Investigator><Investigator ValidYN="Y"><LastName>Hester</LastName><ForeName>Frank</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Harper</LastName><ForeName>Sam</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Douglas</LastName><ForeName>Ian J</ForeName><Initials>IJ</Initials></Investigator><Investigator ValidYN="Y"><LastName>Evans</LastName><ForeName>Stephen J W</ForeName><Initials>SJW</Initials></Investigator><Investigator ValidYN="Y"><LastName>Smeeth</LastName><ForeName>Liam</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Goldacre</LastName><ForeName>Ben</ForeName><Initials>B</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>23</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35764621</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pii">10.1038/s41467-022-30836-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>NICE. Covid-19 rapid guideline: managing the long-term effects of covid-19. https://www.nice.org.uk/guidance/ng188.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani, D. et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. bmj. 372, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Soc. Sci. Med. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre, C. H. et al. Attributes and predictors of long COVID. Nat. Med.27, 10.1038/s41591-021-01292-y (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022;12:446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarraj, J. P. J. et al. Pain and Other Neurological Symptoms Are Present at 3 Months After Hospitalization in COVID-19. Patients. Front. Pain. Res.2, (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8915679</ArticleId><ArticleId IdType="pubmed">35295410</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Group for the GAC-19 P-ACS. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward, H. et al. REACT-2 Round 5: increasing prevalence of SARS-CoV-2 antibodies demonstrate impact of the second wave and of vaccine roll-out in England. Preprint at medRxivhttps://www.medrxiv.org/content/10.1101/2021.02.26.21252512v1 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.26.21252512v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2;M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int. J. Clin. Pract. 2021;7:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxwell E. Living with COVID-19. A dynamic review of the evidence around ongoing COVID-19 symptoms (often called long covid) Natl Inst. Health Res. 2020;31:197&#x2013;200.</Citation></Reference><Reference><Citation>Miyazato, Y. et al. Risk factors associated with development and persistence of long COVID. medRxiv. (2021).</Citation></Reference><Reference><Citation>Amin-Chowdhury Z, Ladhani SN. Causation or confounding: why controls are critical for characterizing long COVID. Nat. Med. 2021;27:1126&#x2013;1127. doi: 10.1038/s41591-021-01402-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01402-w</ArticleId><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker, M. et al. Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508,707 people. http://hdl.handle.net/10044/1/89844 (2021).</Citation></Reference><Reference><Citation>Petersen MS, et al. Long COVID in the Faroe Islands: a longitudinal study among nonhospitalized patients. Clin Infect Dis. 2021;73:e4058&#x2013;e4063. doi: 10.1093/cid/ciaa1792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, et al. Attributes and predictors of long COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AJ, et al. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY. Br. J. of Gen. Pract. 2021;71:e806&#x2013;e814. doi: 10.3399/BJGP.2021.0301.</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/BJGP.2021.0301</ArticleId><ArticleId IdType="pmc">PMC8340730</ArticleId><ArticleId IdType="pubmed">34340970</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin, M. et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg. Health Eur.http://www.ncbi.nlm.nih.gov/pubmed/34027514%0Ahttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC8129613 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Westerlind E, Palstam A, Sunnerhagen KS, Persson HC. Patterns and predictors of sick leave after Covid-19 and long Covid in a national Swedish cohort. BMC Public Health. 2021;21:1&#x2013;9. doi: 10.1186/s12889-021-11013-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11013-2</ArticleId><ArticleId IdType="pmc">PMC8164957</ArticleId><ArticleId IdType="pubmed">34059034</ArticleId></ArticleIdList></Reference><Reference><Citation>Makaronidis J, et al. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people. BMC Infect. Dis. 2021;21:1&#x2013;11. doi: 10.1186/s12879-021-05927-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-05927-w</ArticleId><ArticleId IdType="pmc">PMC7905973</ArticleId><ArticleId IdType="pubmed">33632171</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin, M. et al. Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clin. Microbiol. Infect.10.1016/j.cmi.2021.05.033 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, Y. et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: looking for clarity in the haze of the pandemic. Preprint at medRxiv10.1101/2021.03.03.21252086 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9510954</ArticleId><ArticleId IdType="pubmed">36154716</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmud R, et al. Post-COVID-19 syndrome among symptomatic COVID-19 patients: a prospective cohort study in a tertiary care center of Bangladesh. PLoS ONE. 2021;16:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8031743</ArticleId><ArticleId IdType="pubmed">33831043</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschtick JL, et al. Population-Based Estimates of Post-acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (PASC) Prevalence and Characteristics. Clin. Infect. Dis. 2021;73:2055&#x2013;2064. doi: 10.1093/cid/ciab408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab408</ArticleId><ArticleId IdType="pmc">PMC8240848</ArticleId><ArticleId IdType="pubmed">34007978</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-p&#xe9;rez O, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: a Mediterranean cohort study. J. Infect. J. 2021;82:373&#x2013;378.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh FWJ, et al. Convalescent covid-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife. 2021;10:1&#x2013;23. doi: 10.7554/eLife.64909.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64909</ArticleId><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith GJ, et al. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat. Commun. 2020;11:1&#x2013;12. doi: 10.1038/s41467-020-19478-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19478-2</ArticleId><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference><Reference><Citation>Joshi HE, Fitzsimons E. The UK Millennium Cohort Study: the making of a multi- purpose resource for social science and policy in the UK. Longit. Life Course Stud. 2016;7:409&#x2013;430. doi: 10.14301/llcs.v7i4.410.</Citation><ArticleIdList><ArticleId IdType="doi">10.14301/llcs.v7i4.410</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd A, et al. Cohort profile: The &#x2019;Children of the 90s&#x2019;&#x2014;The index offspring of the avon longitudinal study of parents and children. Int. J. Epidemiol. 2013;42:111&#x2013;127. doi: 10.1093/ije/dys064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys064</ArticleId><ArticleId IdType="pmc">PMC3600618</ArticleId><ArticleId IdType="pubmed">22507743</ArticleId></ArticleIdList></Reference><Reference><Citation>Calderwood, L. &amp; Sanchez, C. Next Steps (formerly known as the Longitudinal Study of Young People in England). Journal of Open Health Data.4, (2016).</Citation></Reference><Reference><Citation>Elliott J, Shepherd P. Cohort profile: 1970 British Birth Cohort (BCS70) Int. J. Epidemiol. 2006;35:836&#x2013;843. doi: 10.1093/ije/dyl174.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyl174</ArticleId><ArticleId IdType="pubmed">16931528</ArticleId></ArticleIdList></Reference><Reference><Citation>Power C, Elliott J. Cohort profile: 1958 British birth cohort (National Child Development Study) Int. J. Epidemiol. 2006;35:34&#x2013;41. doi: 10.1093/ije/dyi183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyi183</ArticleId><ArticleId IdType="pubmed">16155052</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright J, et al. Cohort profile: the born in bradford multi-ethnic family cohort study. Int. J. Epidemiol. 2013;42:978&#x2013;991. doi: 10.1093/ije/dys112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys112</ArticleId><ArticleId IdType="pubmed">23064411</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute for Social and Economic Research. Understanding Society COVID-19 User Guide (Institute for Social and Economic Research, Colchester, 2021).</Citation></Reference><Reference><Citation>Smith BH, et al. Cohort profile: Generation scotland: Scottish family health study (GS: SFHS). The study, its participants and their potential for genetic research on health and illness. Int. J. Epidemiol. 2013;42:689&#x2013;700. doi: 10.1093/ije/dys084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys084</ArticleId><ArticleId IdType="pubmed">22786799</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser A, et al. Cohort profile: the Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort. Int. J. Epidemiol. 2013;42:97&#x2013;110. doi: 10.1093/ije/dys066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dys066</ArticleId><ArticleId IdType="pmc">PMC3600619</ArticleId><ArticleId IdType="pubmed">22507742</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdi S, et al. TwinsUK: the UK Adult Twin Registry update. Twin Res. Hum. Genet. 2019;22:523&#x2013;529. doi: 10.1017/thg.2019.65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/thg.2019.65</ArticleId><ArticleId IdType="pubmed">31526404</ArticleId></ArticleIdList></Reference><Reference><Citation>Snomed C. T. [Internet]. N. H. S. Digital. Available from: https://digital.nhs.uk/services/terminology-and-classifications/snomed-ct (2020).</Citation></Reference><Reference><Citation>O. N. S. Postcode Directory (Latest) Centroids | Open Geography Portal. https://geoportal.statistics.gov.uk/datasets/ons::ons-postcode-directory-latest-centroids/about (2021).</Citation></Reference><Reference><Citation>Mathur R, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021;397:1711&#x2013;1724. doi: 10.1016/S0140-6736(21)00634-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00634-6</ArticleId><ArticleId IdType="pmc">PMC8087292</ArticleId><ArticleId IdType="pubmed">33939953</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W. Conducting meta-analyses in R with the metafor. J. Stat. Softw. 2010;36:1&#x2013;48. doi: 10.18637/jss.v036.i03.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v036.i03</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, M. et al. COVID-19 Survey in Five National Longitudinal Studies: Wave 1, 2 and 3. User Guide (Version 3) (UCL Centre Longitudinal Studies MRC Unit for Lifelong Health and Ageing London, UK) 1&#x2013;62 https://cls.ucl.ac.uk/wp-content/uploads/2021/01/UCL-Cohorts-COVID-19-Survey-user-guide.pdf (2020).</Citation></Reference><Reference><Citation>Pickering S, et al. Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings. PLoS Pathog. 2020;16:e1008817. doi: 10.1371/journal.ppat.1008817.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008817</ArticleId><ArticleId IdType="pmc">PMC7514033</ArticleId><ArticleId IdType="pubmed">32970782</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>